Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16053147 | 1.00 | LMNA (0.40) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL10532824 | 0.86 | LMNA (0.42) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL15012464 | 0.86 | LMNA (0.42) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL15012463 | 0.86 | LMNA (0.42) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL15012441 | 0.86 | LMNA (0.42) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL309591 | 0.86 | LMNA (0.42) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL11715484 | 0.84 | LMNA (0.33) | LMNA | |
| SCHEMBL10568069 | 0.83 | LMNA (0.36) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL27851026 | 0.83 | LMNA (0.40) | LMNAMEN1CYP3A4ALOX15MAPK1 | |
| SCHEMBL12977483 | 0.82 | LMNA (0.38) | LMNAMEN1CYP3A4ALOX15MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 388 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | claimed |
| CN-115427421-B | 3' -Ketoglycoside compounds for slow release of volatile alcohols | 格莱克科学有限公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| EP-4387583-A1 | ANTIMICROBIAL COMPOSITIONS | Firmenich SA (CH) | 2024-06-26 | — | — | EP | claimed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | claimed |
| CN-117881386-A | Antimicrobial compositions | 弗门尼舍有限公司 | 2024-04-12 | — | — | CN | claimed |
| WO-2009000097-A2 | PRESERVATIVE-FREE COMPOSITIONS COMPRISING CINNAMIC OR ANISIC ACID AND A BENZALDEHYDE (DERIVATIVE) | GIVAUDAN SA (CH) | 2008-12-31 | — | — | WO | claimed |
| WO-2008134212-A1 | METHODS FOR TREATING FABRIC IN A DRYER | THE DIAL COMPANY (US) | 2008-11-06 | — | — | WO | claimed |
| US-20080118591-A1 | mixture contains perfume ingredients active against gramnegative bacteria; alcohols, aldehydes, ketones, imines, esters compound; low concentrations of Triclosan or other phenolic biocides; for disinfection, cleaning; liquid soaps for washing, shampoo; oral care products, mouth wash, tooth paste | GIVAUDAN SA (CH) | 2008-05-22 | — | — | US | claimed |
| US-20080021098-A1 | Antifungal Compositions | GIVAUDAN SA (CH) | 2008-01-24 | — | — | US | claimed |
| EP-1853214-A1 | BACTERICIDAL FORMULATIONS | Givaudan SA (CH) | 2007-11-14 | — | — | EP | claimed |
| WO-2006053458-A1 | BACTERICIDAL FORMULATIONS | GIVAUDAN SA (CH) | 2006-05-26 | — | — | WO | claimed |
| WO-2005079573-A1 | ANTIFUNGAL COMPOSITIONS | GIVAUDAN SA (CH) | 2005-09-01 | — | — | WO | claimed |
| EP-1056739-B1 | NOVEL CYCLIC PRO-PERFUMES HAVING MODIFIABLE FRAGRANCE RAW MATERIAL ALCOHOL RELEASE RATE | PROCTER & GAMBLE (US) | 2003-05-02 | — | — | EP | claimed |
| US-6500797-B1 | Process for preparing β-ketoester fragrance pro-accords from 1,3-dioxan-4,6-diones | THE PROCTER & GAMBLE COMPANY | 2002-12-31 | — | — | US | claimed |
| EP-0053716-A1 | Terpene ethers, their production and use, and perfume compositions containing them | Henkel Kommanditgesellschaft auf Aktien (DE) | 1982-06-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021098-A1 | Antifungal Compositions | ERG28, DPM1, SORD | LMNA 418/4885MEN1 3503/4885CYP3A4 228/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | LMNA 2003/4885MEN1 3970/4885CYP3A4 1704/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | LMNA 4339/4885MEN1 2771/4885CYP3A4 388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.